(5R)-5-[2-[[(3R)-5-fluoro-11-oxo-1,7-diazatricyclo[6.3.1.04,12]dodeca-4(12),5,7,9-tetraen-3-yl]methylamino]ethyl]-3-(3-oxo-4H-1,4-benzothiazin-6-yl)-1,3-oxazolidin-2-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: (5R)-5-[2-[[(3R)-5-fluoro-11-oxo-1,7-diazatricyclo[6.3.1.04,12]dodeca-4(12),5,7,9-tetraen-3-yl]methylamino]ethyl]-3-(3-oxo-4H-1,4-benzothiazin-6-yl)-1,3-oxazolidin-2-one
• 化学式: C₂₄H₂₂FN₅O₄S
• 分子量: 495.5
• InChiKey: UJAAXQJSNTZZCE-UKRRQHHQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  35
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  129
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS
  申请人：HUBSCHWERLEN Christian

  公开号：US20140142093A1

  公开（公告）日：2014-05-22

  The present invention relates to antibacterial compounds of formula (I) wherein “----” is a bond or is absent, V is CH, CR 6 or N; R 0 is H or, if “----” is a bond, may also be alkoxy; R 1 is cyano, alkyl, or ethynyl; U is CH or N when “----” is a bond, or, if “----” is absent, U is CH 2 , NH or NH 9 ; R 2 is H, alkylcarbonyl or CH 2 —R 3 ; R 3 is H, alkyl or hydroxyalkyl; R 4 is H or, if n is not 0 and R 5 is H, may also be OH; R 5 is H, alkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl, carboxy or alkoxycarbonyl; R 6 is hydroxyalkyl, carboxy, alkoxycarbonyl or —(CH 2 ) q —NR 7 R 8 , q being 1, 2 or 3 and each of R 7 and R 8 independently being H or alkyl or R 7 and R 8 forming with the N atom bearing them a ring; R 9 is alkyl or hydroxyalkyl; A is —(CH 2 ) p —, —CH 2 CH 2 CH(OH)— or —COCH 2 CH(OH)—; G is substituted phenyl or G 1 or G 2 , wherein Q is O or S and X is CH or N; and Y 1 , Y 2 and Y 3 may each be CH or N; and n is 0 when A is —CH 2 CH 2 CH(OH)— or —COCH 2 CH(OH)—, and n is 0, 1 or 2 when A is —(CH 2 ) p —, p being 1, 2, 3 or 4, with the proviso that the sum of n and p is then 2, 3 or 4; and to salts of such compounds.

  本发明涉及式（I）的抗菌化合物，其中“----”是键或不存在，V是CH，CR6或N；R0是H或，如果“----”是键，则也可以是烷氧基；R1是氰基，烷基或乙炔基；当“----”是键时，U是CH或N，如果“----”不存在，则U是CH2，NH或NH9；R2是H，烷基羰基或CH2—R3；R3是H，烷基或羟基烷基；R4是H或，如果n不为0且R5是H，则也可以是OH；R5是H，烷基，羟基烷基，氨基烷基，烷氧基烷基，羧基或烷氧羰基；R6是羟基烷基，羧基，烷氧羰基或—（CH2）q—NR7R8，其中q为1、2或3，每个R7和R8独立地为H或烷基，或R7和R8与它们所带的N原子形成环；R9是烷基或羟基烷基；A是—（CH2）p—，—CH2CH2CH（OH）—或—COCH2CH（OH）—；G是取代苯基或G1或G2，其中Q为O或S，X为CH或N；Y1、Y2和Y3可以各自是CH或N；当A为—CH2CH2CH（OH）—或—COCH2CH（OH）—时，n为0，当A为—（CH2）p—时，n为0、1或2，p为1、2、3或4，但总和n和p为2、3或4；以及这些化合物的盐。
• Lubricant Compositions Comprising Epoxide Compounds
  申请人：BASF SE

  公开号：US20140142009A1

  公开（公告）日：2014-05-22

  A lubricant composition including an epoxide compound is disclosed. An additive package including the epoxide compound is also disclosed. The epoxide compound of the lubricant composition acts to improve compatibility of the lubricant composition with a fluoropolymer seal and improve the total base number of the lubricant composition.
• LUBRICANT COMPOSITIONS COMPRISING EPOXIDE COMPOUNDS
  申请人：BASF SE

  公开号：US20170029737A1

  公开（公告）日：2017-02-02

  A lubricant composition including an epoxide compound is disclosed. An additive package including the epoxide compound is also disclosed. The epoxide compound of the lubricant composition acts to improve compatibility of the lubricant composition with a fluoropolymer seal and improve the total base number of the lubricant composition.
• Lubricant Composition
  申请人：BASF SE

  公开号：US20190322958A1

  公开（公告）日：2019-10-24

  A lubricant composition includes a base oil and an additive package. The additive package includes a seal compatibility additive chosen from a halide seal compatibility additive, an epoxide seal compatibility additive, a boroxine seal compatibility additive, a sulfonate ester seal compatibility additive, and combinations thereof. The alkoxylated amide and the ester are set forth in general formulas A and B, respectively: In general formulas A and B, each R 13 , R II , R III , and R IV , is, independently, a linear or branched, saturated or unsaturated, hydrocarbyl group. In addition, at least one of R II and R III include an alkoxy group, and R IV includes an amine group.
• US9346804B2
  申请人：——

  公开号：US9346804B2

  公开（公告）日：2016-05-24